Article Text
PDFImage of the moment
Horner’s syndrome and apraclonidine eye drops
Statistics from Altmetric.com
Footnotes
Contributors All authors contributed equally to the writing/revision of the manuscript and obtaining the data for the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Obtained.
Provenance and peer review Not commissioned; externally peer reviewed by Luke Bennetto, Bristol, UK.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Read the full text or download the PDF:
Other content recommended for you
- Nasopharyngeal carcinoma presenting as a sixth nerve palsy and Horner ’s syndrome
- Unequal pupils and ptosis
- Confirmation of Horner 's syndrome using apraclonidine eye drops
- Sudden onset of pain in the eye and blurring of vision
- The sensitivity and specificity of 0.5 % apraclonidine in the diagnosis of oculosympathetic paresis
- Eye drop neurology
- Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: a simple test to identify this condition
- Neuro - ophthalmological presentation of giant intracavernous carotid artery aneurysm in a child
- Patient use of Visine (tetrahydrozoline) masks Horner syndrome
- Neuro - ophthalmology